Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Shastri

Showing results (131-140 of 132) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 132 results.
Papillomavirus Research (Amsterdam, Netherlands)|February 4, 2019
Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years - updated evidence from Indian follow-up cohort studyPartha Basu, Richard Muwonge, Neerja Bhatla, et al.
The Lancet. Oncology|December 15, 2015
Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort studyRengaswamy Sankaranarayanan, Priya Ramesh Prabhu, Michael Pawlita, et al.
Pageof 14

Showing results (131-140 of 132) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 132 results.
Papillomavirus Research (Amsterdam, Netherlands)|February 4, 2019
Two-dose recommendation for Human Papillomavirus vaccine can be extended up to 18 years - updated evidence from Indian follow-up cohort studyPartha Basu, Richard Muwonge, Neerja Bhatla, et al.
The Lancet. Oncology|December 15, 2015
Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort studyRengaswamy Sankaranarayanan, Priya Ramesh Prabhu, Michael Pawlita, et al.
Pageof 14